The primary input to deciding on the merit of proposals submitted to the NIH for potential funding, as most of my remaining blog audience well knows, is the outcome of the initial peer-review proce…| DrugMonkey
If you are an R01-funded researcher, the NIH center grant might be a fulfilling way to expand the impact of your work. If you are a research development professional, it may be a novel way to align research strengths and encourage collaboration among entities on your campus. But when do you know you are ready […]| Bouvier Grant Group
An NIH-funded partnership between JHU and Howard University speeds the development of medical devices addressing neurological disorders that affect more than a billion people| The Hub
NIH funding helps Johns Hopkins pediatric surgeons conduct lifesaving research to repair congenital diaphragmatic hernias| The Hub
Engineer Denis Wirtz and colleagues are using artificial intelligence and multiscale imaging to reveal how tumors grow, spread, and vary across populations| The Hub
For some leukemia patients, each hour of delayed care can be the difference between life and death. JHU's Eugene Shenderov is developing an AI algorithm to help doctors reach faster diagnoses.| The Hub
Hopkins researchers identified three types of zombie skin cells; only one gets worse with age| The Hub
Hopkins engineer Vicky Nguyen has spent 15 years studying how glaucoma progresses to figure out how to preserve patients' vision| The Hub
Federal funding supports engineer Jeff Wang's work to create affordable devices that expand access to health care, leading to faster diagnosis and better health outcomes| The Hub
For more than half a century, Johns Hopkins has been a leader in converting federal support into tangible benefits for the American people| The Hub
Cancer researcher Chi Van Dang studies pharmacokinetics—the way the body absorbs, distributes, metabolizes, and excretes a drug at different times of day. His work on treatment timing holds promise for improving patient outcomes.| The Hub
Community bonds and NIH funding have helped scientists at a Johns Hopkins research field center in Hagerstown, Maryland, collect some of the world's best population-based data on cardiovascular disease risk| The Hub
Lord, the gaslighting. There’s a live one commenting on the blog post about my disappointment with Mike Lauer’s accomplishments vis a vis the Ginther gap while he headed up the OER at NIH. I don’t know if this person is a current or past NIH employee or merely an apologist. I don’t even know if […]| DrugMonkey
I am sort of fascinated to see if NIH has learned any lessons from the past year of ultra chaos. As you are well aware, Dear Reader, I have been a long time complainer about the NIH ICs that choose to drag their feet on funding grants under a continuing resolution. I am particularly critical […]| DrugMonkey
Mike Lauer, prior head of the Office of Extramural Research at the NIH, has been quoted in a recent Nature news bit by Max Kozlov on the Fiscal Year 2025 grant funding picture. Kozlov writes, in part, about the way that Multi-Year Funding has decreased the number of new grant awards, thereby letting success rates […]| DrugMonkey
We’re almost updated on FY2025 funding, as the grants funded since 9/20 have hit the books and Jeremy Berg noted on BlueSky that the overall amount of money committed to grants by the NIH for FY2025 is 99.0% of the amount committed to grants in FY2024. I say almost, because we could still have awards […]| DrugMonkey
Fueled by federal funding, JHU researchers and scientists seek investors to back their ideas to bring discoveries to the market| The Hub
This novel approach could significantly reduce the need for invasive, often painful biopsies| The Hub
Hopkins cancer expert Liz Jaffee discusses what federal budget cuts might mean for patient care and future cures; NIH grant terminations affect some of the nation's most promising young scientists, including two Hopkins doctoral students| The Hub
Bernie was born with congenital glaucoma, a condition that requires urgent intervention. A team of pediatric ophthalmologists at Wilmer Eye Institute acted quickly to save her eyesight.| The Hub
Federal budget cuts have created "a climate of anxiety" among medical researchers, says Maximilian F. Konig, a rheumatologist at Johns Hopkins. But those who live with autoimmune diseases could suffer the greatest consequences.| The Hub
The Johns Hopkins-led OUtMATCH study, which enrolled clinical trial participants at 10 locations across the U.S., leads to the second-ever FDA-approved food allergy treatment| The Hub
Cuts to NIH funding for biostatistical research would erode the United States' competitive edge, hindering the health, economy, and overall security of the nation| The Hub
When I finally grasped the initial salvo on the multi-year funding policy, it was buttressed by a comment in the President’s/NIH’s FY2026 budget justification/request [PDF] In FY 2026, …| DrugMonkey
Q: In these times of volatility with federal agencies, are there strategies I can use to maximize my chances of funding success? Tip: We are in an era of rapid and unprecedented changes. While you can’t control the funding landscape, you can control how you respond to it. A: We are in an uncertain and […] The post Strategies to Maximize Funding Success in Uncertain Times appeared first on Bouvier Grant Group.| Bouvier Grant Group
The transition to the Common Forms is back on! The Forms are anticipated to be available in November 2025. In 2024, we told you about the transition to the Common Forms for Biographical Sketches and Other Support. That initiative was paused in March of this year as part of the Trump administration’s changes at NIH. […]| Bouvier Grant Group
Experts at Johns Hopkins and across the country work together to better understand the behavior and characteristics of respiratory viruses, how our immune system responds to them, and how we can prevent serious illness| The Hub
Propublica has published a report on the loss of staff positions at various government agencies since January of 2025. This includes a list of percent losses at each NIH IC due to firings, layoffs,…| DrugMonkey
Researchers like Richard Huganir are closing in on a cure for SYNGAP1-related disorders. But in the face of federal funding cuts, can they finish what they started?| The Hub
NIH released several important notices over the last few weeks. Below is a brief summary of each item. To read each complete notice (NOT): https://grants.nih.gov/policy-and-compliance/notice-of-policy-changes Supporting Fairness and Originality in NIH Research Applications. NIH is evaluating applications closely for substantial use of AI. NIH also will now only accept a maximum of 6 applications per […]| Bouvier Grant Group
Following up on yesterday’s whinesplaining about the relative difficulty of getting a NIH grant across pertinent career eras, I had some more thoughts on generational expectations and gasligh…| DrugMonkey
There’s a parable about a coyote and a rabbit that ends with the coyote being criticized by a bystander after observing his fruitless chase. The coyote observed, “I was only running for…| DrugMonkey
You have an idea for a full-scale clinical trial that you would like to eventually fund with an R01. How do you go from concept to R01 funding for the full-scale trial? NIH has several funding mechanisms that can help you lay the groundwork for a future R01-funded trial. Here, we outline some of the […] The post Spotlight on R34, R21, R61/R33: NIH Mechanisms to Help You Prepare for a Future R01-funded clinical trial appeared first on Bouvier Grant Group.| Bouvier Grant Group
The NIH DP2 activity code supports highly innovative research by new investigators in all areas of biomedical and behavioral research. NIH currently has three active DP2 Notices of Funding Opportunity (NOFO). We’ve summarized them for you below. It is always a good idea to speak with the program officers of these NOFOs to determine whether […] The post A Comparison of 3 NIH New Innovator Awards (DP2): Office of the Director High-Risk, High-Reward; NIDA; and NIAID appeared first on Bouvier...| Bouvier Grant Group
I have received a lot of requests lately for help writing an NIH rebuttal, so it seems like a good time to talk about what they are and how to write one. Rebuttals seem to go in and out of vogue at NIH, and for whatever reason right now, many program officers (POs) are requesting […]| Bouvier Grant Group
Among the 187 US institutions described as a R1 for 2025, Howard University has been included for the first time. This is the first Historically Black College or University (HBCU) to achieve this high level of research activity and this is a very welcome bit of news. For those not familiar, the Carnegie rankings are […]| Drugmonkey
[Update: The Chronicle is reporting as of 2/10/2025 that F31-diversity applications have been re-instated to the study sections for review. If true, this is excellent news.] One of the primary NIH training fellowships is the Ruth L. Kirschstein Predoctoral Individual National Research Service Award for graduate students, aka, the F31. It is requested with individual […]| Drugmonkey
A genetic mutation and evolutionary trick fuels horses' exceptional athleticism, findings that may advance scientific understanding and treatments for inherited and age-related diseases in people| The Hub
Falls are the leading cause of injury-related death among seniors in the United States. Johns Hopkins researcher Kathleen Cullen studies the vestibular system in our inner ear, integral to maintaining balance.| The Hub
JHU's Neurofibromatosis Therapeutic Acceleration Program celebrated the 10th anniversary of its Francis S. Collins Scholars Program, an initiative that has led to research and treatment breakthroughs for the genetic condition neurofibromatosis type 1| The Hub
NIH has issued NOT-OD-25-132 Supporting Fairness and Originality in NIH Research Applications which informs us that NIH will only accept six new, renewal, resubmission, or revision applications fro…| DrugMonkey
The NIH Director’s New Innovator Award (activity code DP2) supports Early-Stage Investigators (ESIs) who are pursuing highly innovative research that has the potential to have a major impact on areas relevant to NIH mission. Applications can be basic, translational, or clinical in nature. The Notice of Funding Opportunity (RFA-RM-25-002) allows for clinical trials, though it […] The post Spotlight on the NIH Director’s New Innovator Award – DP2 appeared first on Bouvier Grant Group.| Bouvier Grant Group
Health science researchers in the U.S. naturally gravitate toward National Institutes of Health (NIH) grants to fund their work, but other sources are available. And with the looming threat of NIH budget cuts, interest in alternatives may be on the rise. One such (perhaps surprising?) resource: the U.S. Department of Defense (DOD). You’re familiar with […]| Bouvier Grant Group
I receive a lot of questions from worried applicants and clients about how to navigate the volatile NIH funding landscape.| Bouvier Grant Group
The Center on Aging and Health, one of JHU's largest recipients of NIH funds, conducts critical work that provides real-time insights into the condition and care of older Americans| The Hub
Backed by NIH funding, Muyinatu 'Bisi' Bell's innovative work is enhancing diagnostic accuracy, improving surgical precision, and ensuring equitable health care for all patients| The Hub
Electrical engineer Mounya Elhilali relies on federal funding to push the boundaries of how technology can enhance human perception| The Hub
Johns Hopkins scientists develop mRNA "booster" as potential new way to treat rare genetic diseases marked by too low levels of specific cellular proteins| The Hub
In February 2024, we brought you a first installment regarding AI and grantwriting courtesy of colleague and guest writer Dr. Agnella Izzo Matic. As you may imagine, the topic of AI as a whole and, similarly, AI as it relates to grantwriting and scientific writing is evolving. For a bit of background into what AI is, […]| Bouvier Grant Group
Guest Post by Dr. Agnella Izzo Matic TL;DR – AI is a new tool that can (and should) be leveraged to speed up some specific parts of the writing process that can be automated – saving time and mental bandwidth for the parts of the process that need idea generation and critical analysis. AI won’t […]| Bouvier Grant Group
